Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management